Fintel reports that on December 17, 2025, JP Morgan maintained coverage of CVS Health (NYSE:CVS) with a Overweight ...

In December 2025, CVS Health raised its 2025 guidance to at least US$400.0 billion in revenue and higher GAAP operating income, while also forecasting a US$5.73 billion goodwill impairment. At the ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round ...

Retail pharmacy chain CVS Health’s ($CVS) shares are up 81.86% year-to-date despite subsidiary Omnicare’s recent Texas ...

Louisiana will settle all three lawsuits against CVS Health for roughly $50 million, Attorney General Liz Murrill said ...

CVS announced its plan to launch a new healthcare engagement platform in order to “uniquely reimagine health care through ...

CVS Health Ventures leads $35M funding round for Codoxo, advancing AI-powered payment integrity to improve payer-provider accuracy.

Louisiana Attorney General Liz Murrill announced that a settlement is imminent in three lawsuits against CVS Health. The ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady ...